Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2016, Article ID 2872371, 7 pages
http://dx.doi.org/10.1155/2016/2872371
Clinical Study

Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients

1Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Centre, MBC-11, P.O. Box 3354, Riyadh 11211, Saudi Arabia
2Alfaisal University, College of Medicine, Riyadh, Saudi Arabia
3Liver & Small Bowel Transplant and Hepatobiliary and Pancreatic Surgery-Organ Transplant Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
4King Saud University, College of Medicine, Riyadh, Saudi Arabia

Received 3 November 2015; Accepted 10 November 2015

Copyright © 2016 A. Ajlan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

A. Ajlan, A. Al-Jedai, H. Elsiesy, et al., “Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients,” Canadian Journal of Gastroenterology and Hepatology, vol. 2016, Article ID 2872371, 7 pages, 2016. https://doi.org/10.1155/2016/2872371.